Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

Simply Wall St.10-06

When you see that almost half of the companies in the Professional Services industry in Hong Kong have price-to-sales ratios (or "P/S") below 0.4x, Jinhai Medical Technology Limited (HKG:2225) looks ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2473513370?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967","is_english":true,"pubTime":"2024-10-06 08:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473513370","market":"us","top_or_hot":-1,"title":"Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price","media":"Simply Wall St.","content":"<div>\n<p>When you see that almost half of the companies in the Professional Services industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 0.4x, Jinhai Medical Technology Limited (HKG:2225) looks ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/commercial-services/hkg-2225/jinhai-medical-technology-shares/news/why-were-not-concerned-about-jinhai-medical-technology-limit\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-06 08:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/commercial-services/hkg-2225/jinhai-medical-technology-shares/news/why-were-not-concerned-about-jinhai-medical-technology-limit><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When you see that almost half of the companies in the Professional Services industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 0.4x, Jinhai Medical Technology Limited (HKG:2225) looks ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/commercial-services/hkg-2225/jinhai-medical-technology-shares/news/why-were-not-concerned-about-jinhai-medical-technology-limit\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02225","symbol_name":"今海医疗科技","start_time":0,"source_url":"https://simplywall.st/stocks/hk/commercial-services/hkg-2225/jinhai-medical-technology-shares/news/why-were-not-concerned-about-jinhai-medical-technology-limit","article_id":"2473513370","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473513370","pubTimestamp":1728174226,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When you see that almost half of the companies in the Professional Services industry in Hong Kong have price-to-sales...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"02225":"今海医疗科技","BK1150":"人力资源与就业服务"},"translate_title":"为什么我们不关心金海医疗科技有限公司（HKG：2225）的股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02225":1},"content_text":"When you see that almost half of the companies in the Professional Services industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 0.4x, Jinhai Medical Technology Limited (HKG:2225) looks to be giving off strong sell signals with its 20x P/S ratio.   Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so lofty.     View our latest analysis for Jinhai Medical Technology SEHK:2225 Price to Sales Ratio vs Industry October 6th 2024 What Does Jinhai Medical Technology's Recent Performance Look Like?  Jinhai Medical Technology certainly has been doing a great job lately as it's been growing its revenue at a really rapid pace.   It seems that many are expecting the strong revenue performance to beat most other companies over the coming period, which has increased investors’ willingness to pay up for the stock.  You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.     We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Jinhai Medical Technology's earnings, revenue and cash flow.   How Is Jinhai Medical Technology's Revenue Growth Trending?   There's an inherent assumption that a company should far outperform the industry for P/S ratios like Jinhai Medical Technology's to be considered reasonable.   Taking a look back first, we see that the company grew revenue by an impressive 205% last year.    The latest three year period has also seen an excellent 226% overall rise in revenue, aided by its short-term performance.  Therefore, it's fair to say the revenue growth recently has been superb for the company.     When compared to the industry's one-year growth forecast of 10%, the most recent medium-term revenue trajectory is noticeably more alluring  With this in consideration, it's not hard to understand why Jinhai Medical Technology's P/S is high relative to its industry peers.  It seems most investors are expecting this strong growth to continue and are willing to pay more for the stock.    The Key Takeaway  Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.  It's no surprise that Jinhai Medical Technology can support its high P/S given the strong revenue growth its experienced over the last three-year is superior to the current industry outlook.  Right now shareholders are comfortable with the P/S as they are quite confident revenue aren't under threat.  Barring any significant changes to the company's ability to make money, the share price should continue to be propped up.      Plus, you should also learn about these 2 warning signs we've spotted with Jinhai Medical Technology (including 1 which can't be ignored).   If you're unsure about the strength of Jinhai Medical Technology's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2473513370"}